Since OAT2 and RFC1 are the major transporters of 5-FU and LV (13,15), respectively, the expression levels of OAT2 and RFC1 may be candidate biomarkers for the prediction of tumor response to UFT/LV chemotherapy. The gene discussed is RFC1; the disease is neoplasm.